Gene therapy patients monitored for years in new safety study
NCT ID NCT06798298
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 24 times
Summary
This study follows about 50 people who have already received gene modified T cell therapy in earlier trials. Researchers will check for delayed side effects, how long the modified cells last, and whether the disease gets worse. Participants will have regular check-ups and fill out questionnaires about their quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG TERM SAFETY FOLLOWING GM T CELL THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tennessee Oncology
RECRUITINGNashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.